US National Cancer Institute investigates PSA coding errors.
about
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer.Validation of prostate-specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries.Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer.Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
P2860
US National Cancer Institute investigates PSA coding errors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
US National Cancer Institute investigates PSA coding errors.
@en
US National Cancer Institute investigates PSA coding errors.
@nl
type
label
US National Cancer Institute investigates PSA coding errors.
@en
US National Cancer Institute investigates PSA coding errors.
@nl
prefLabel
US National Cancer Institute investigates PSA coding errors.
@en
US National Cancer Institute investigates PSA coding errors.
@nl
P1433
P1476
US National Cancer Institute investigates PSA coding errors.
@en
P356
10.1016/S1470-2045(15)70196-8
P577
2015-04-30T00:00:00Z